Article
Inhibition of Aerobic Glycolysis Represses Akt/mTOR/HIF-1α Axis and Restores Tamoxifen Sensitivity in Antiestrogen-Resistant Breast Cancer Cells.
PloS one - 1 Jan 2015
Woo Yu Mi, Shin Yubin, Lee Eun Ji, Lee Sunyoung, Jeong Seung Hun, Kong Hyun Kyung, Park Eun Young, Kim Hyoung Kyu, Han Jin, Chang Minsun, Park Jong-Hoon
Abstract excerpt
Tamoxifen resistance is often observed in the majority of estrogen receptor-positive breast cancers and it remains as a serious clinical problem in breast cancer management. Increased aerobic glycolysis has been proposed as one of the mechanisms for acquired resistance to chemotherapeutic agents in breast cancer cells such as adriamycin. Herein, we report that the glycolysis rates in LCC2 and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
